Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period ended September 30, 2014.
“We believe Spectrum is at the threshold of a multi-year growth story,” said Rajesh C. Shrotriya, MD, Chairman and Chief Executive Officer of Spectrum Pharmaceuticals. “This quarter exemplifies the execution of Spectrum’s business model.
Help employers find you! Check out all the jobs and post your resume.
“We believe Spectrum is at the threshold of a multi-year growth story,” said Rajesh C. Shrotriya, MD, Chairman and Chief Executive Officer of Spectrum Pharmaceuticals. “This quarter exemplifies the execution of Spectrum’s business model.
Help employers find you! Check out all the jobs and post your resume.
